Literature DB >> 7915522

Autoxidation of drugs: prediction of degradation impurities from results of reaction with radical chain initiators.

G Boccardi1.   

Abstract

In the study of the degradation of drug substances by molecular oxygen, their specific reaction mechanisms must be taken into account. The rate-determining step is usually the reaction of the substrate with a radical chain initiator, which is often an unknown impurity. The reactivity and selectivity of autoxidation can be controlled better by using a radical chain initiator, such as AIBN, than by changing the temperature or the oxygen pressure. In this paper the products profiles of four pharmaceutical substances in a simple oxidation test with AIBN are compared with the results of long term natural stability tests or with already established stabilities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915522

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  6 in total

1.  Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.

Authors:  Darren L Reid; C Jeffrey Calvitt; Mark T Zell; Kenneth G Miller; Carol A Kingsmill
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

2.  Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 2: Safety considerations of impurities in pharmaceutical products and surveying the impurity landscape.

Authors:  Karen M Alsante; Kim C Huynh-Ba; Steven W Baertschi; Robert A Reed; Margaret S Landis; Scott Furness; Bernard Olsen; Mark Mowery; Karen Russo; Robert Iser; Gregory A Stephenson; Patrick Jansen
Journal:  AAPS PharmSciTech       Date:  2013-12-21       Impact factor: 3.246

3.  Use of 2,2'-azobis(2-amidinopropane) dihydrochloride as a reagent tool for evaluation of oxidative stability of drugs.

Authors:  Seema Betigeri; Ajit Thakur; Krishnaswamy Raghavan
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

4.  Development and Validation of Stability-Indicating HPLC Methods for the Estimation of Lomefloxacin and Balofloxacin Oxidation Process under ACVA, H2O2, or KMnO4 Treatment. Kinetic Evaluation and Identification of Degradation Products by Mass Spectrometry.

Authors:  Barbara Żuromska-Witek; Paweł Żmudzki; Marek Szlósarczyk; Anna Maślanka; Urszula Hubicka
Journal:  Molecules       Date:  2020-11-11       Impact factor: 4.411

Review 5.  Oxidation of Drugs during Drug Product Development: Problems and Solutions.

Authors:  Alen Gabrič; Žiga Hodnik; Stane Pajk
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

6.  Assessment of Diverse Solid-State Accelerated Autoxidation Methods for Droperidol.

Authors:  Jayant Iyer; Isha Saraf; Andrew Ray; Michael Brunsteiner; Amrit Paudel
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.